{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "aab351a6",
   "metadata": {},
   "source": [
    "# Import the dataset"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "f8903647",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "86137c0f",
   "metadata": {},
   "outputs": [],
   "source": [
    "train_df = pd.read_csv('dataset/csv/train.csv')\n",
    "test_df = pd.read_csv('dataset/csv/test.csv')\n",
    "val_df = pd.read_csv('dataset/csv/dev.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "ad1be5f9",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>line_number</th>\n",
       "      <th>discourse_type</th>\n",
       "      <th>discourse_text</th>\n",
       "      <th>total_lines</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>24464531</td>\n",
       "      <td>0</td>\n",
       "      <td>OBJECTIVE</td>\n",
       "      <td>To investigate the efficacy of 6 weeks of dail...</td>\n",
       "      <td>12</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>24464531</td>\n",
       "      <td>1</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>A total of 125 patients with primary knee OA w...</td>\n",
       "      <td>12</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>24464531</td>\n",
       "      <td>2</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>Outcome measures included pain reduction and i...</td>\n",
       "      <td>12</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>24464531</td>\n",
       "      <td>3</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>Pain was assessed using the visual analog pain...</td>\n",
       "      <td>12</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>24464531</td>\n",
       "      <td>4</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>Secondary outcome measures included the Wester...</td>\n",
       "      <td>12</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>180035</th>\n",
       "      <td>24464531</td>\n",
       "      <td>7</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>For the absolute change in percent atheroma vo...</td>\n",
       "      <td>12</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>180036</th>\n",
       "      <td>24464531</td>\n",
       "      <td>8</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>For PAV , a significantly greater percentage o...</td>\n",
       "      <td>12</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>180037</th>\n",
       "      <td>24464531</td>\n",
       "      <td>9</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>Both strategies had acceptable side effect pro...</td>\n",
       "      <td>12</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>180038</th>\n",
       "      <td>24464531</td>\n",
       "      <td>10</td>\n",
       "      <td>CONCLUSIONS</td>\n",
       "      <td>Compared with standard statin monotherapy , th...</td>\n",
       "      <td>12</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>180039</th>\n",
       "      <td>24464531</td>\n",
       "      <td>11</td>\n",
       "      <td>CONCLUSIONS</td>\n",
       "      <td>( Plaque Regression With Cholesterol Absorptio...</td>\n",
       "      <td>12</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>180040 rows Ã— 5 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "              ID  line_number discourse_type  \\\n",
       "0       24464531            0      OBJECTIVE   \n",
       "1       24464531            1        METHODS   \n",
       "2       24464531            2        METHODS   \n",
       "3       24464531            3        METHODS   \n",
       "4       24464531            4        METHODS   \n",
       "...          ...          ...            ...   \n",
       "180035  24464531            7        RESULTS   \n",
       "180036  24464531            8        RESULTS   \n",
       "180037  24464531            9        RESULTS   \n",
       "180038  24464531           10    CONCLUSIONS   \n",
       "180039  24464531           11    CONCLUSIONS   \n",
       "\n",
       "                                           discourse_text  total_lines  \n",
       "0       To investigate the efficacy of 6 weeks of dail...           12  \n",
       "1       A total of 125 patients with primary knee OA w...           12  \n",
       "2       Outcome measures included pain reduction and i...           12  \n",
       "3       Pain was assessed using the visual analog pain...           12  \n",
       "4       Secondary outcome measures included the Wester...           12  \n",
       "...                                                   ...          ...  \n",
       "180035  For the absolute change in percent atheroma vo...           12  \n",
       "180036  For PAV , a significantly greater percentage o...           12  \n",
       "180037  Both strategies had acceptable side effect pro...           12  \n",
       "180038  Compared with standard statin monotherapy , th...           12  \n",
       "180039  ( Plaque Regression With Cholesterol Absorptio...           12  \n",
       "\n",
       "[180040 rows x 5 columns]"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "train_df"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "71b32c8d",
   "metadata": {},
   "source": [
    "# Explore data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "b2365bdf",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "METHODS        59353\n",
       "RESULTS        57953\n",
       "CONCLUSIONS    27168\n",
       "BACKGROUND     21727\n",
       "OBJECTIVE      13839\n",
       "Name: discourse_type, dtype: int64"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "train_df.discourse_type.value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "b9b1e0ce",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<AxesSubplot:>"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "train_df.total_lines.hist()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "9eebeaf4",
   "metadata": {},
   "source": [
    "Most of the abstracts are between 7 to 15"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "be259808",
   "metadata": {},
   "source": [
    "## Get lists of sentences"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "fcb04e64",
   "metadata": {},
   "outputs": [],
   "source": [
    "DISCOURSE_TEXT_LABEL = \"discourse_text\"\n",
    "train_sentences = train_df[DISCOURSE_TEXT_LABEL].tolist()\n",
    "test_sentences = test_df[DISCOURSE_TEXT_LABEL].tolist()\n",
    "val_sentences = val_df[DISCOURSE_TEXT_LABEL].tolist()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "dcbf224e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['To investigate the efficacy of 6 weeks of daily low-dose oral prednisolone in improving pain , mobility , and systemic low-grade inflammation in the short term and whether the effect would be sustained at 12 weeks in older adults with moderate to severe knee osteoarthritis ( OA ) .',\n",
       " 'A total of 125 patients with primary knee OA were randomized 1:1 ; 63 received 7.5 mg/day of prednisolone and 62 received placebo for 6 weeks .',\n",
       " 'Outcome measures included pain reduction and improvement in function scores and systemic inflammation markers .',\n",
       " 'Pain was assessed using the visual analog pain scale ( 0-100 mm ) .',\n",
       " 'Secondary outcome measures included the Western Ontario and McMaster Universities Osteoarthritis Index scores , patient global assessment ( PGA ) of the severity of knee OA , and 6-min walk distance ( 6MWD ) .',\n",
       " 'Serum levels of interleukin 1 ( IL-1 ) , IL-6 , tumor necrosis factor ( TNF ) - , and high-sensitivity C-reactive protein ( hsCRP ) were measured .',\n",
       " 'There was a clinically relevant reduction in the intervention group compared to the placebo group for knee pain , physical function , PGA , and 6MWD at 6 weeks .',\n",
       " 'The mean difference between treatment arms ( 95 % CI ) was 10.9 ( 4.8-18 .0 ) , p < 0.001 ; 9.5 ( 3.7-15 .4 ) , p < 0.05 ; 15.7 ( 5.3-26 .1 ) , p < 0.001 ; and 86.9 ( 29.8-144 .1 ) , p < 0.05 , respectively .',\n",
       " 'Further , there was a clinically relevant reduction in the serum levels of IL-1 , IL-6 , TNF - , and hsCRP at 6 weeks in the intervention group when compared to the placebo group .',\n",
       " 'These differences remained significant at 12 weeks .']"
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "train_sentences[:10]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "a71b87b3",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.8"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
